Health economics analysis reveals the substantial burden of cardiovascular diseases across the European Union, highlighting urgent needs for standardized CVD-specific data and research funding.
CVD is a leading public health problem. Our study is the first to assess the economic burden of CVD across the EU, and our results should help policy makers evaluate policy impact and prioritize research expenditures. However, because of data unavailability, our study has important limitations, which highlight the need for more accurate and comparable CVD-specific information.
No takes yet. Share an insight, caveat, or question.
Leal et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: